AusPAR: insulin degludec/liraglutide

Australian Public Assessment Report

AusPAR

AusPAR: insulin degludec/liraglutide [PDF, 399.41 KB]

AusPAR: insulin degludec/liraglutide [Word, 172.89 KB]

Attachment 1: Product Information for insulin degludec/liraglutide [PDF, 757.88 KB]

Attachment 1: Product Information for insulin degludec/liraglutide [Word, 2.45 MB]

Device/Product Name

Xultophy

Active ingredients

insulin degludec/liraglutide

AusPAR Date

22 March 2021

Published

15 April 2021

Submission Number

PM 2019 05122-1-5

Submission Type

New combination of active ingredients

Decision

Approved